BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3326155)

  • 1. [New etiopathogenic and therapeutic findings in bullous skin diseases].
    Rozsívalová V; Jelínková R; Salavec M; Chýlková V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1986; 29(4-5):497-512. PubMed ID: 3326155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of therapeutic effect of extracorporeal detoxication in autoimmune bullous dermatoses].
    Grando SA; Glukhen'kiĭ BT; Romanenko AB; Chaiun OA; Dolia SV
    Vestn Dermatol Venerol; 1988; (7):6-11. PubMed ID: 3064487
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological studies of patients with vesicular diseases].
    Seidlová A
    Cesk Stomatol; 1983 Jul; 83(4):245-50. PubMed ID: 6375878
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bullous diseases and their monitoring at the dermatology clinic].
    Rozsívalová V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1987; 30(5):687-94. PubMed ID: 3333100
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasma exchange therapy in pemphigus vulgaris and bullous pemphigoid--our clinical experiences and the role of bullous pemphigoid antibody in blister formation].
    Watanabe S
    Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):953-64. PubMed ID: 6363766
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasmapheresis in the treatment of bullous skin diseases].
    Neumann E; Skalisz H; Bowszyc J
    Przegl Dermatol; 1980; 67(4):487-92. PubMed ID: 7001548
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune bullous dermatoses.
    Cunha PR; Barraviera SR
    An Bras Dermatol; 2009; 84(2):111-24. PubMed ID: 19503978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathological aspects of autoimmune bullous dermatoses].
    Grando SA; Glukhen'kiĭ BT; Kutsenko NS; Kostromin AP; Demidov SV
    Vrach Delo; 1987 Sep; (9):94-7. PubMed ID: 3321707
    [No Abstract]   [Full Text] [Related]  

  • 9. Concomitant immunohistochemical characteristics of pemphigoid and dermatitis herpetiformis in a patient with atypical bullous dermatosis.
    de Jong MC; van der Meer JB; de Nijs JA; van der Putte SC
    Acta Derm Venereol; 1983; 63(6):476-82. PubMed ID: 6198835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesiculobullous skin disease with prominent immunologic feature.
    Millikan LE
    JAMA; 1987 Nov; 258(20):2910-5. PubMed ID: 3312674
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment Update of Autoimmune Blistering Diseases.
    Kridin K; Ahn C; Huang WC; Ansari A; Sami N
    Dermatol Clin; 2019 Apr; 37(2):215-228. PubMed ID: 30850044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of beta 1H globulin in pemphigus, bullous pemphigoid and dermatitis herpetiformis (author's transl)].
    Sugiura M
    Nihon Hifuka Gakkai Zasshi; 1982 May; 92(6):629-34. PubMed ID: 6213797
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune bullous diseases.
    Rye B; Webb JM
    Am Fam Physician; 1997 Jun; 55(8):2709-18. PubMed ID: 9191456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathology of pemphigus vulgaris, bullous pemphigoid and related bullous dermatoses.
    Patel HP; Anhalt GJ; Provost TT; Diaz LA
    Clin Immunol Rev; 1983-1984; 2(2):157-86. PubMed ID: 6370527
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunology of bullous diseases-II. Cicatricial pemphigoid. Herpes gestationis and dermatitis herpetiformis].
    Díaz-Pérez JL; Jordón RE
    Med Cutan Ibero Lat Am; 1977; 5(6):403-13. PubMed ID: 368462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous pemphigoid and pemphigus vulgaris.
    Patel HP; Anhalt GJ; Diaz LA
    Ann Allergy; 1983 Mar; 50(3):144-50. PubMed ID: 6338766
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of immunofluorescent techniques in studies of bullous disease.
    Maize JC; Provost TT
    Am J Dermatopathol; 1983 Feb; 5(1):67-72. PubMed ID: 6344686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of raised production of eicosanoids during the increase of immunosuppressive activity of the serum after hemosorption].
    Grando SA; Drannik GN
    Biull Eksp Biol Med; 1990 Feb; 109(2):172-4. PubMed ID: 2186817
    [No Abstract]   [Full Text] [Related]  

  • 19. Three blistering diseases. Why proper management is critical.
    Wooldridge WE
    Postgrad Med; 1990 Sep; 88(3):103-4, 106. PubMed ID: 2204894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesiculobullous skin diseases with prominent immunologic feature.
    Zweiman B; Millikan LE
    JAMA; 1982 Nov; 248(20):2623-6. PubMed ID: 6754973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.